Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2167974 | 0.97 | SMN1; SMN2 (0.36) | SMN1; SMN2FDPS | |
| SCHEMBL4873469 | 0.82 | SMN1; SMN2 (0.32) | SMN1; SMN2FDPS | |
| SCHEMBL13024053 | 0.80 | FDPS (0.35) | SMN1; SMN2FDPS | |
| SCHEMBL14008530 | 0.80 | FDPS (0.35) | SMN1; SMN2FDPS | |
| SCHEMBL13066092 | 0.74 | SMN1; SMN2 (0.37) | SMN1; SMN2FDPS | |
| SCHEMBL4866498 | 0.74 | — | — | |
| SCHEMBL17377285 | 0.72 | SMN1; SMN2 (0.35) | SMN1; SMN2FDPS | |
| SCHEMBL20905549 | 0.72 | SMN1; SMN2 (0.35) | SMN1; SMN2FDPS | |
| SCHEMBL486195 | 0.72 | SMN1; SMN2 (0.35) | SMN1; SMN2FDPS | |
| SCHEMBL4876275 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7335781-B2 | Aminothiol compound | HUEY JIIN CO., LTD. (TW) | 2008-02-26 | — | — | US | disclosed |
| US-7335781-B2 | Aminothiol compound | HUEY JIIN CO., LTD. (TW) | 2008-02-26 | — | — | US | disclosed |
| US-7335781-B2 | Aminothiol compound | HUEY JIIN CO., LTD. (TW) | 2008-02-26 | — | — | US | disclosed |
| US-20040181057-A1 | perform as superior catalysts in asymmetric addition reactions wherein organic zinc and aldehyde are involved; Such catalyses are economically useful for industries | HUEY JIIN CO., LTD. (TW) | 2004-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040181057-A1 | perform as superior catalysts in asymmetric addition reactions wherein organic zinc and aldehyde are involved; Such catalyses are economically useful for industries | ALDH7A1, ALDH3A1, ALDH1A1 | SMN1; SMN2 4102/4885FDPS 1181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.